SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001626129-17-000327
Filing Date
2017-04-28
Accepted
2017-04-28 16:37:33
Documents
2
Period of Report
2017-06-20
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT fmi-def14a_062017.htm DEF 14A 424847
2 GRAPHIC tcox-sign.jpg GRAPHIC 7437
  Complete submission text file 0001626129-17-000327.txt   436237
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Filer) CIK: 0001488613 (see all company filings)

IRS No.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36086 | Film No.: 17796235
SIC: 8071 Services-Medical Laboratories